Quantcast

Latest Belleville, Ontario Stories

2014-07-29 08:32:30

BELLEVILLE, ON, July 29, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced the submission to the US Food and Drug Administration (FDA) Office of Orphan Products Development, an application for Orphan Drug Designation for its Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory/relapsing high grade non-muscle invasive bladder cancer. The decision to proceed...

2014-06-13 08:24:29

BELLEVILLE, ON, June 13, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) - ("Bioniche" or the "Company"), a clinical stage biotechnology company whose anchor product is a Phase III treatment for non-muscle-invasive bladder cancer, today announced that Dr. Michael Berendt, Chief Executive Officer and Chief Scientist of Bioniche Life Sciences Inc., will present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference at the Toronto Board of Trade on...

2014-06-03 08:33:08

BELLEVILLE, ON, June 3, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today provided corporate updates on a number of key strategic initiatives including: -- Continued execution of Cost Reduction/Strategic Expenditures Review -- Completion of Asset Disposition Program -- Vaccine Manufacturing (VMC) Sales Process -- Urocidin(TM) Regulatory Update Strategic Expenditures Review Initiated in December 2013, management...

2014-04-15 20:23:13

LURE, FRANCE and BELLEVILLE, ON, April 15, 2014 /PRNewswire/ - Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced the closing of the sale of Bioniche's Animal Health business to Vétoquinol. The two companies announced the signing of a share purchase agreement in February that was subject to the approval of Bioniche shareholders. At a Special Meeting of Shareholders held yesterday, 97.4% of the Shares that were voted were in...

2014-04-14 12:36:38

BELLEVILLE, ON, April 14, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that its shareholders have voted in favour of the sale of the Company's Animal Health business to Vétoquinol SA. At a Special Meeting of Shareholders held this morning in Toronto, 39.4% of the issued and outstanding shares were voted, with 97.4% of those voting in favour of the sale transaction. The transaction is expected to close tomorrow. About Bioniche Life Sciences...

2014-04-03 16:24:27

BELLEVILLE, ON, April 3, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that it has successfully monetized two non-core properties for net proceeds in excess of $1 million. Over the past several months, the Board of Directors and management team have developed and have been implementing a strategic expenditures review which included identifying and divesting non-core assets. The sale of the property adjacent to the Company's Belleville, Ontario...

2014-02-27 16:28:54

LURE, FRANCE and BELLEVILLE, ON, Feb. 27, 2014 /PRNewswire/ - Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche's Animal Health business for the cash purchase price of CAD$61 million. This agreement remains subject to the approval by shareholders of Bioniche Life Sciences Inc., and the usual closing conditions for a...

2014-01-07 16:25:42

BELLEVILLE, ON, Jan. 7, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a leading clinical stage biotechnology company, today announced the appointment of Donald Olds as Chief Operating Officer, effective immediately. Dr. Michael Berendt, CEO of Bioniche Life Sciences Inc., highlighted that, "the engagement of Donald Olds as Chief Operating Officer is the next step in our operational plan to position Bioniche Life Sciences as a top-tier North American...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.